Tag: Atypical hemolytic uremic syndrome

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Atypical hemolytic uremic syndrome

AstraZeneca expands global footprint in rare disease with availability of first Alexion ... - Cision News

Added to Collection on: 2022-11-11 07:19:06

Tags for this article:

Medical specialties
Medicine
Health
Rare diseases
Blood disorders
Acquired hemolytic anemia
Alexion Pharmaceuticals
Eculizumab
Atypical hemolytic uremic syndrome
Paroxysmal nocturnal hemoglobinuria
Hemolytic anemia
Neuromyelitis optica
Soliris
Alexion Pharmaceuticals Inc.
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
AstraZeneca bringing rare disease medicine to patients in China - BioPharma-Reporter

Added to Collection on: 2022-11-14 18:22:21

Tags for this article:

Medical specialties
Medicine
Rare diseases
Organ systems
Blood disorders
Acquired hemolytic anemia
Autoimmune diseases
Atypical hemolytic uremic syndrome
Syndromes
Eculizumab
Paroxysmal nocturnal hemoglobinuria
Hemolytic–uremic syndrome
Soliris

Click the tags to see associated articles and topics

View Article Details
Global Soliris Market 2022 Research Analysis | Alexion - Eagle's Eye

Added to Collection on: 2022-12-05 18:04:56

Tags for this article:

Business
Articles
Economy
Eculizumab
Immunosuppressants
Market analysis
Atypical hemolytic uremic syndrome
Market research
Market segmentation
Value chain
Mergers and acquisitions
Market
Soliris

Click the tags to see associated articles and topics

View Article Details
Global PNH and aHUS Market 2022 Analysis by Company Share and Growth - Eagle's Eye

Added to Collection on: 2022-12-05 14:52:16

Tags for this article:

Articles
Health
Eculizumab
Immunosuppressants
Alexion Pharmaceuticals
Atypical hemolytic uremic syndrome
Market research
Market segmentation
Market analysis
Pharmaceutical industry in China
Ahus
PNH

Click the tags to see associated articles and topics

View Article Details
Patented Medicine Prices Review Board Issues a Notice of Hearing for Allegations of ...

Added to Collection on: 2024-04-02 19:40:49

Tags for this article:

Eculizumab
Immunosuppressants
Alexion Pharmaceuticals
Patented Medicine Prices Review Board
Medication
Atypical hemolytic uremic syndrome
Pricing
Pharmaceutical industry
Alexion Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Long-Term Data Affirm Efficacy of Eculizumab in Refractory Generalized MG

Added to Collection on: 2024-04-15 20:56:51

Tags for this article:

Monoclonal antibodies
Orphan drugs
Immunosuppressants
Autoimmune diseases
Eculizumab
Myasthenia gravis
Rare diseases
Ravulizumab
Apheresis
Atypical hemolytic uremic syndrome

Click the tags to see associated articles and topics

View Article Details
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy ... - PR Newswire

Added to Collection on: 2024-05-25 16:02:46

Tags for this article:

Kidney diseases
Glomerulopathy
Glomerulonephritis
IgA nephropathy
Membranoproliferative glomerulonephritis
Atypical hemolytic uremic syndrome
Renal biopsy
Kidney disease
Igan
Alternative complement pathway
Atrasentan
Novartis AG

Click the tags to see associated articles and topics

View Article Details
Atypical Hemolytic Uremic Syndrome Treatment Market 2034: - openPR.com

Added to Collection on: 2024-08-26 15:17:01

Tags for this article:

Blood disorders
Monoclonal antibodies
Acquired hemolytic anemia
Nephrology
Ahus
Complement system
Atypical hemolytic uremic syndrome
Alexion Pharmaceuticals
Hemolytic–uremic syndrome
Hemolysis
Complement factor I
Eculizumab

Click the tags to see associated articles and topics

View Article Details
Rare Kidney Diseases Treatment Market Size Hits USD 15.13 - openPR.com

Added to Collection on: 2024-09-02 10:36:02

Tags for this article:

Kidney diseases
Rare diseases
Lysosomal storage diseases
Kidney disease
Atypical hemolytic uremic syndrome
Fabry disease
Lupus nephritis
Lupus
Rare disease
Kidney
Cystinosis
Nephritis

Click the tags to see associated articles and topics

View Article Details
CDSCO approves AstraZeneca's anti-complement medicine Eculizumab - Express Pharma

Added to Collection on: 2025-01-17 16:04:40

Tags for this article:

Acquired hemolytic anemia
Blood disorders
Rare diseases
Hematology
Atypical hemolytic uremic syndrome
Syndromes
Hemolytic–uremic syndrome
Hemolysis
Eculizumab
Thrombotic microangiopathy
Paroxysmal nocturnal hemoglobinuria
Ahus
ASTRAZENECA PHARMA INDIA

Click the tags to see associated articles and topics

View Article Details